Coming Next: Calendar Year 2017/2018

On July 12th, 2017 we announced our acquisition of Math Resolution’s Assets including Dosimetry Check. Our plans are to incorporate all of Dosimetry Check’s dose calculation functionality into the current RadCalc fully automated platform. This expanded QA platform will provide all of RadCalc’s core dose verification and 3D Dose Volume for Brachytherapy functionality while adding a new 3D Dose Volume suite that includes support for conventional linac and TomoTherapy®, EPID based patient Pre-treatment and Exit-Transit dose for In-Vivo dosimetry as well as its 3D dose volume verification package that utilizes a collapsed cone convolution/superposition algorithm dose engine.

The combined QA Software Package will include the first fully automated Pre-Treatment and 3D In-Vivo Exit dose verification software and provides a complete suite of 3D Dose Volume verification analysis tools which include Image Analysis and EPID based measurement functions. We hope to have this integration completed, cleared by the appropriate regualtory agencies, and released before the end of 2017.

On July 24th we announced our acquisition of Radify Monte Carlo QA Technology from McGill University. The integration of the Radify technology will immediately improve accessibility to the significant advantage of Monte Carlo accuracy in clinical settings, specifically for verifying photon, electron, and proton treatment plans. We hope to have a beta version out later in 2017, then in 2018, and after filing and receiving the appropriate regulatory clearances, we anticipate releasing a new RadCalc module that will provide fast and accurate 3D Monte Carlo Dose Volume verification for photon and electron calculations. We will provide more detailed information on our website when we are closer to a release date.

You are here: Home RadCalc Future Releases